Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer

[1] Vincent A(2011)Pancreatic cancer Lancet 378 607-20

[2] Herman J(2003)Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer Cancer Res 63 2649-57

[3] Schulick R(2012)New biomarkers and targets in pancreatic cancer and their application to treatment Nat Rev Gastroenterol Hepatol 9 435-44

[4] Hruban RH(2002)Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation Am J Pathol 160 45-50

[5] Goggins M(2012)Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency Genome Res 22 208-19

[6] Logsdon CD(2012)Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue PLoS One 7 e34151-45

[7] Simeone DM(2012)MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma Clin Cancer Res 18 534-95

[8] Binkley C(2012)Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma Int J Canc 131 E86-52

[9] Arumugam T(2012)Mirna expression profiles identify drivers in colorectal and pancreatic cancers PLoS One 7 e33663-709

[10] Greenson JK(2007)MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma Oncogene 26 4442-40

[1] Vincent A(2011)Pancreatic cancer Lancet 378 607-20

[2] Herman J(2003)Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer Cancer Res 63 2649-57

[3] Schulick R(2012)New biomarkers and targets in pancreatic cancer and their application to treatment Nat Rev Gastroenterol Hepatol 9 435-44

[4] Hruban RH(2002)Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation Am J Pathol 160 45-50

[5] Goggins M(2012)Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency Genome Res 22 208-19

[6] Logsdon CD(2012)Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue PLoS One 7 e34151-45

[7] Simeone DM(2012)MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma Clin Cancer Res 18 534-95

[8] Binkley C(2012)Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma Int J Canc 131 E86-52

[9] Arumugam T(2012)Mirna expression profiles identify drivers in colorectal and pancreatic cancers PLoS One 7 e33663-709

[10] Greenson JK(2007)MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma Oncogene 26 4442-40